1. Canada Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
COSCIENS Biopharma Inc.

COSCIENS Biopharma Inc.

CSCI.TO
COSCIENS Biopharma Inc.CA flagToronto Stock Exchange
3.70
CAD
+0.04
- -
3.93MMarket Cap

Total Valuation

COSCIENS Biopharma Inc. carries a market capitalization of 3.93M, placing it among publicly traded companies globally. Its enterprise value stands at 846,902.22, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.93M
Enterprise Value846,902.22

Share Statistics

COSCIENS Biopharma Inc. currently has 3.18M shares outstanding.

Shares Outstanding3.18M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

COSCIENS Biopharma Inc. trades at a trailing price-to-earnings ratio of 0.94. The price-to-sales ratio is 0.49, and the price-to-book ratio stands at 0.30.

PE Ratio0.94
PS Ratio0.49
PB Ratio0.30
P/TBV Ratio0.25
P/FCF Ratio-0.47
P/OCF Ratio-0.44

Enterprise Valuation

EV / Sales0.11
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

COSCIENS Biopharma Inc. maintains a current ratio of 5.57, meaning it holds 5.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.21, indicating elevated leverage, while an interest coverage ratio of -43.57 demonstrates limited ability to service its debt obligations.

Current Ratio5.57
Quick Ratio4.15
Debt / Equity13.21
Debt / EBITDA-0.32
Interest Coverage-43.57

Financial Efficiency

Return on Equity (ROE)39.13
Return on Assets (ROA)16.22
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.75

Taxes

Income Tax11,000.00
Effective Tax RateN/A

Stock Price Statistics

COSCIENS Biopharma Inc.'s stock has declined approximately -74.03509% over the past 52 weeks. The 50-day moving average sits at 2.92, while the 200-day moving average is 2.88.

Beta (5Y)N/A
52-Week Price Change-74.03509%
50-Day Moving Average2.92
200-Day Moving Average2.88
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, COSCIENS Biopharma Inc. generated 7.89M in revenue and converted that into 4.05M in net income, yielding earnings per share of -6.16. EBITDA reached -6.27M, while operating income came in at -7.48M.

Revenue7.89M
Gross Profit3.00M
Operating Income-7.48M
Pretax Income-6.87M
Net Income4.05M
EBITDA-6.27M
EBIT-7.48M
Earnings Per Share (EPS)-6.16

Balance Sheet

COSCIENS Biopharma Inc. holds 5.01M in cash and equivalents against 2.02M in total debt, resulting in a net debt position of -5.00M. Total book value stands at 12.87M, with working capital of 7.71M providing operational flexibility.

Cash & Cash Equivalents5.01M
Total Debt2.02M
Net Debt-5.00M
Equity (Book Value)12.87M
Book Value Per Share12.21
Working Capital7.71M

Cash Flow

COSCIENS Biopharma Inc. produced -8.77M in operating cash flow over the past twelve months. After subtracting -97,000.00 in capital expenditures, free cash flow totaled -8.87M - equivalent to -8.41 per share.

Operating Cash Flow-8.77M
Capital Expenditures-97,000.00
Free Cash Flow-8.87M
FCF Per Share-8.41

Margins

COSCIENS Biopharma Inc. operates with a gross margin of 38.00, reflecting its pricing power and cost economics. The operating margin of -94.83 and net profit margin of 51.41 provide insight into operational efficiency.

Gross Margin38.00
Operating Margin-94.83
Pretax Margin-87.18
Profit Margin51.41
EBITDA Margin-79.56

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield7.55
FCF Yield-213.62

Stock Splits

COSCIENS Biopharma Inc.'s most recent stock split took place on July 3, 2026 with a 3:1 split ratio.

Last Split Date7/3/2026
Split Ratio3:1

Scores

COSCIENS Biopharma Inc. posts an Altman Z-Score of -0.47, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.47